| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.903798 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107180347 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 211004e202111##onc ob f000 0 eng d |
|---|
| 020 | |a9780660405223 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-29/2021E-PDF |
|---|
| 245 | 00|aPOL-0030 : |bcompliance and enforcement approach and inspection strategy for clinical trials of drugs involving human subjects. |
|---|
| 246 | 30|aCompliance and enforcement approach and inspection strategy for clinical trials of drugs involving human subjects |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cNovember, 2021. |
|---|
| 264 | 4|c©2021 |
|---|
| 300 | |a1 online resource (25 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: POL-0030 : approche en matière de conformité et d'application de la loi et stratégie d'inspection pour les essais cliniques de médicaments sur des sujets humains. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (pages 24-25). |
|---|
| 610 | 10|aCanada. |tFood and Drugs Act. |
|---|
| 650 | 0|aDrugs|xTesting|xLaw and legislation|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tPOL-0030 : |w(CaOODSP)9.903799 |
|---|
| 856 | 40|qPDF|s971 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H139-29-2021-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/guidance-documents/inspection-strategy-clinical-trials.html |
|---|
| 986 | |aPub.: 210352 |
|---|